Press release Luebeck, August 9th, 2017 EUROIMMUN is pleased to announce that European Patent EP2514837 has been revoked in its entirety in opposition proceedings by the European Patent Office in their decision dated July 7, 2017. The claims of the patent as granted relate to a method for detecting brain damage caused by Alzheimer’s disease […]
Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable
In fall 2016, EUROIMMUN Canada celebrated the opening of its new facilities in Mississauga, Ontario.
On 22 September, EUROIMMUN celebrated the roofing ceremony of the new “House of Engineers” in Dassow, only 14 months after the official laying of the cornerstone. About 60 guests were invited, including the administrative head of the district, Mrs. Weiss, Minister of Economics, Construction and Tourism in Mecklenburg-West Pomerania, Mr. Glawe, and the Deputy Mayor
In summer 2016, Análisis Y Genética S. L. (Madrid, Spain) and ANAGENE, LDA. (Amadora, Portugal) were incorporated into the EUROIMMUN Group as new subsidiaries after 16 years of successful distribution partnership. All 16 experienced employees and the managing director for many years of Análisis Y Genética S. L., Pedro Cayuela, remain with the Spanish subsidiary,
